Pilot Evaluation of AboutFace: Novel Peer Education Resource for Veterans
22. mai 2019 oppdatert av: VA Office of Research and Development
Pilot Evaluation of AboutFace: A Novel Peer Education Resource for Veterans
The purpose of this study is to evaluate the AboutFace peer education website for the purpose of reducing stigma and improving attitudes toward seeking mental health services among Veterans.
Studieoversikt
Detaljert beskrivelse
Research suggests that at least 1 in 10 Veterans will meet criteria for posttraumatic stress disorder (PTSD) related to their military experience.
Treatment is widely available to Veterans with PTSD, and national dissemination initiatives have increased Veterans' access to best practice interventions.
However, treatment seeking remains strikingly low among Veterans with PTSD.
In fact, most Veterans with PTSD do not seek mental health services due to perceived stigma and other associated barriers.
The National Center for PTSD recently developed and launched AboutFace, a peer education resource for Veterans.
The investigators of this study believe that AboutFace has tremendous potential to reduce stigma and improve attitudes toward seeking mental health services among Veterans.
However, it has not yet been evaluated.
Investigators have partnered with the National Center for PTSD to launch this mixed methods pilot evaluation of AboutFace.
There will be two phases to this study.
During Phase I- Usability, 20 Veterans will be recruited to participate in individual interviews during which they will be asked to describe the ease of use of the AboutFace website for the researchers.
During Phase II- Feasibility, 60 Veterans will be randomized to one of two conditions- About Face or Usual Care.
All participants will complete several brief assessments measuring PTSD symptoms and attitudes toward seeking mental health services.
Participants will then be randomized to either receive a link to the About Face website or to receive a link to a general online brochure about PTSD.
After two weeks, participants will complete the assessment measures once again to determine any changes in attitudes toward seeking mental health services and potential changes in PTSD symptoms.
Studietype
Intervensjonell
Registrering (Faktiske)
60
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
South Carolina
-
Charleston, South Carolina, Forente stater, 29401-5799
- Ralph H. Johnson VA Medical Center, Charleston, SC
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Must be 18 years of age
- Recommended for PTSD treatment following evaluation
- Internet access
- English Speaking
Exclusion Criteria:
- Minors under the age of 18
- Non-Veterans
- Negative for PTSD
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Phase II- Experimental Group
Participants were provided with instructions and a web link for accessing the AboutFace website after the baseline assessment.
|
AboutFace is an informational website that utilizes digital storytelling to describe PTSD symptoms and different treatments for PTSD.
|
|
Ingen inngripen: Phase II- Usual Care Group
Participants were provided with instructions and a web link for accessing some online PTSD education materials after the baseline assessment.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Endorsed and Anticipated Stigma Inventory (EASI)
Tidsramme: pre-treatment (baseline) & post-treatment (two-week) assessment
|
THE EASI assesses for perceptions of treatment effectiveness, stigma, and external barriers to treatment seeking. Answers are ranked from 1 to 5 with 1 being "Strongly Disagree" and 5 being "Strongly Agree" and higher scores are indicative of greater stigma. Total scores can range from 40 to 190. Phase I participants did not participate in Phase II (the clinical trial portion of the study) and were not assessed using this measure. |
pre-treatment (baseline) & post-treatment (two-week) assessment
|
|
PTSD Checklist (PCL-V)
Tidsramme: pre-treatment (baseline) & post-treatment (2-week) assessment
|
The PCL-V is a 20-item self-report measure that assesses PTSD severity. Individual item responses can range from 0-4 with 0 being "Not At All" and 4 being "Extremely" and total scores can range from 0 to 80. Higher numbers on the PCL-V are indicative of greater PTSD severity. Phase I participants did not participate in Phase II (the clinical trial portion of the study) and were not assessed using this measure. |
pre-treatment (baseline) & post-treatment (2-week) assessment
|
|
PTSD Treatment Initiators
Tidsramme: two weeks post assessment
|
percentage/rate of PTSD treatment initiation at post assessment (2-weeks) Phase I participants did not participate in Phase II (the clinical trial portion of the study) and were not assessed using this measure.
|
two weeks post assessment
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Kenneth J Ruggiero, PhD MA BA, Ralph H. Johnson VA Medical Center, Charleston, SC
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Kreuze E, Jenkins C, Gregoski M, York J, Mueller M, Lamis DA, Ruggiero KJ. Technology-enhanced suicide prevention interventions: A systematic review. J Telemed Telecare. 2017 Jul;23(6):605-617. doi: 10.1177/1357633X16657928. Epub 2016 Jul 3.
- Hamblen JL, Grubaugh AL, Davidson TM, Borkman AL, Bunnell BE, Ruggiero KJ. An Online Peer Educational Campaign to Reduce Stigma and Improve Help Seeking in Veterans with Posttraumatic Stress Disorder. Telemed J E Health. 2019 Jan;25(1):41-47. doi: 10.1089/tmj.2017.0305. Epub 2018 May 10.
- Bunnell BE, Davidson TM, Hamblen JL, Cook DL, Grubaugh AL, Lozano BE, Tuerk PW, Ruggiero KJ. Protocol for the evaluation of a digital storytelling approach to address stigma and improve readiness to seek services among veterans. Pilot Feasibility Stud. 2017 Feb 17;3:7. doi: 10.1186/s40814-017-0121-3. eCollection 2017.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. april 2015
Primær fullføring (Faktiske)
1. september 2016
Studiet fullført (Faktiske)
1. desember 2016
Datoer for studieregistrering
Først innsendt
16. juni 2015
Først innsendt som oppfylte QC-kriteriene
26. juni 2015
Først lagt ut (Anslag)
1. juli 2015
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
5. juni 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
22. mai 2019
Sist bekreftet
1. mai 2019
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- PPO 14-360
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .